| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | 0.22 | 1e-10 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.19 | 2e-10 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | 0.21 | 2e-10 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.23 | 2e-10 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | 0.21 | 4e-10 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.32 | 6e-10 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.19 | 6e-10 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | 0.23 | 8e-10 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | 0.22 | 1e-09 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.21 | 1e-09 |